Grifols SA - ADR - Level III Live Share Price Today, Share Analysis and Chart

Name: Grifols SA - ADR - Level III: Is Infosys Ltd. worth buying?
Item: Grifols SA - ADR - Level III
Rating: 2.31166675
Author: Trendlyne DVM scores

about

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once i...

9.93 -0.01 (-0.10%)

New 52W High in past week

846.8K

XNAS Volume

XNAS 21 Jul, 2025 1:52 PM (EDT)

Board Meeting

The next board meeting for Grifols SA - ADR - Level III is on 30 Jul 2025 for the purpose of Grifols SA Second Quarter Earnings Results for 2025 See details

Not Eligible

Expensive Valuation

25.7 / 100

Technically Moderately Bullish

66.8 / 100

1Yr Price target upside is 23%

2 analysts

Grifols SA - ADR - Level III Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..